Amber Implants
Manufacturing · Netherlands · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Prinses Margrietplantsoen 33, The Hague,...Phone Number
+31 152002151Website
www.amberimplants.comRevenue
$5.5 MillionIndustry
About Amber Implants
Is Amber Implants your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Amber Implants is spiking on competitors!
Amber Implants, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Amber Implants had a recent Job posting/layoffs
Product Launch: Get notified when Amber Implants launches new products
Funding: Get notified immidiatlly once Amber Implants has new funding data
Earning: See what the market has to say on Amber Implants recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Amber Implants
Website visits: Recent activity has been detected on your website
Check if Amber Implants has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Amber Implants as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Amber Implants is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Amber Implants is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Amber Implants.
Amber Implants Tech Stack
A closer look at the technologies used by Amber Implants
Amber Implants News & Media
Amber Implants Advances Pivotal European EXPAND Study of VCFix® Spinal System in Standalone Vertebral Reconstruction
Study evaluates VCFix® used with or without bone cement, expanding clinical experience with the company’s minimally invasive spine platform. Study evaluates VCFix® used with or without bone cement, expanding clinical experience with the company’s minimally invasive spine platform.Amber Implants Appoints Vincent Gardès as Chief Executive Officer to Drive Commercial Launch of VCFix® Spinal System
Experienced MedTech leader to guide Amber Implants' transition from development into commercialization following FDA clearance of the VCFix® Spinal System Company preparing for U.S. market launch in 2026 THE HAGUE, The Netherlands, Nov. 6, 2025 /PRNewswire/ -- Amber Implants, an...Amber Implants Secures FDA 510(k) Clearance for VCFix® Spinal System: A Next-Generation Solution for Vertebral Compression Fractures
FDA clearance confirms robust safety and performance of VCFix® Spinal System, a breakthrough treatment for vertebral compression fractures US commercial pilot launch planned for early 2026, followed by broader physician availability from summer 2026 One-year trial data show significant...Amber Implants Announces Successful One-Year Follow-Up Data in First-in-Human Clinical Trial of VCFix® Spinal System
- One-year follow-up data from first-in-human trial shows significant improvements in key clinical performance outcomes - This data supports a strong safety profile for the VCFix® Spinal System for the treatment of vertebral compression fractures THE HAGUE, Netherlands, June 3, 2025...
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Amber Implants
Amber Implants is a medical technology start-up located in the Netherlands and United States. Founded in 2018, the Company has developed the next generation of spinal implants for Vertebral Compression Fractures (VCF), and is focussed on improving patient outcomes through implants that provide more natural healing and stability. Amber Implants aims... Read More